EarningsQ3 2024 Earnings Report

Galectin Therapeutics (PHPN) Q3 2024 Earnings Report

0 Followers

DE:PHPN Q3 2024 EPS Results

Actual EPS-€0.16

Consensus EPS-€0.17

Beat/MissBeat by +€0.02

One Year Ago EPS-€0.21

Actual Revenue€0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ3 2024

Date11/14/2024

TimeBefore Open

Conference CallThursday, November 14, 2024

DE:PHPN Upcoming Earnings

Galectin Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 16, 2026	2026 (Q3)	-0.04 / -	-0.113	―
Aug 14, 2026	2026 (Q2)	-0.08 / -0.12	-0.104	-16.67% (-0.02)
May 15, 2026	2026 (Q1)	- / -0.07	-0.13	46.67% (+0.06)
Mar 31, 2026	2025 (Q4)	-0.05 / -0.07	-0.13	46.67% (+0.06)
Nov 14, 2025	2025 (Q3)	-0.10 / -0.11	-0.156	27.78% (+0.04)
Aug 14, 2025	2025 (Q2)	-0.14 / -0.10	-0.173	40.00% (+0.07)
May 15, 2025	2025 (Q1)	- / -0.13	-0.165	21.05% (+0.03)
Mar 31, 2025	2024 (Q4)	-0.17 / -0.13	-0.165	21.05% (+0.03)
Nov 14, 2024	2024 (Q3)	-0.17 / -0.16	-0.208	25.00% (+0.05)
Aug 13, 2024	2024 (Q2)	-0.14 / -0.17	-0.13	-33.33% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed